Parker Laboratories, Inc.: Redux Electrolyte Creme Recalled for Low Viscosity

Agency Publication Date: April 19, 2024

Summary

Parker Laboratories, Inc. is recalling 217 cases (totaling 10,850 individual units) of Redux Electrolyte Creme, Product Ref. 66-04. This highly conductive creme, used in medical procedures, is being recalled because the product demonstrates low viscosity, meaning it is thinner or more watery than intended. This defect may affect the product's performance or application during medical use. The affected batches were distributed worldwide and across 15 U.S. states between November 2022 and May 2023.

Risk

The low viscosity of the electrolyte creme may lead to improper application or insufficient conductivity during medical procedures. While no injuries have been reported, inconsistent product thickness can compromise the quality of medical readings or treatments requiring a conductive medium.

What You Should Do

Check your supply of Redux Electrolyte Creme (Product Ref. 66-04) for the following Lot Numbers and Expiration Dates: Lot A1122010 (Expiration 11/29/25) and Lot A0523002 (Expiration 5/12/26).
Verify the Unique Device Identifier (UDI) numbers on the packaging: 20855683006399 (Master Case), 10855683006392 (Inner Box), or 00855683006395 (Individual Unit).
If you identify affected product, stop using it immediately and set it aside to prevent further use.
Contact your healthcare provider or Parker Laboratories, Inc. at their Fairfield, New Jersey facility for further instructions and information regarding a potential refund or replacement.
For additional questions or to report a problem, contact the FDA at 1-888-463-6332 or visit www.fda.gov/medical-devices/medical-device-recalls.

Your Remedy Options

Other Action

Contact healthcare provider or manufacturer

How to: Contact your healthcare provider or the manufacturer for further instructions and potential refund

Affected Products

Product: Redux Electrolyte Creme, Product Ref. 66-04

Model / REF:

66-04

UDI: 20855683006399 (Master)

UDI: 10855683006392 (Inner Box)

UDI: 00855683006395 (Each)

Lot Numbers:

A1122010 (Exp 11/29/25)

A0523002 (Exp 5/12/26)

Date Ranges: 11/29/25, 5/12/26

Additional Information

Agency: Food and Drug Administration (FDA)

Event ID: 94303

Status: Active

Manufacturer: Parker Laboratories, Inc.

Sold By: Medical distributors; Authorized retailers

Manufactured In: United States

Units Affected: 217 cases (1,085 Inner Boxes; 10,850 Eaches)

Distributed To: California, Colorado, Florida, Georgia, Illinois, Maryland, Michigan, Minnesota, North Carolina, Nebraska, New York, Ohio, Pennsylvania, South Carolina, Texas

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.

Summary

What You Should Do

Check your supply of Redux Electrolyte Creme (Product Ref. 66-04) for the following Lot Numbers and Expiration Dates: Lot A1122010 (Expiration 11/29/25) and Lot A0523002 (Expiration 5/12/26).

Verify the Unique Device Identifier (UDI) numbers on the packaging: 20855683006399 (Master Case), 10855683006392 (Inner Box), or 00855683006395 (Individual Unit).

If you identify affected product, stop using it immediately and set it aside to prevent further use.

Contact your healthcare provider or Parker Laboratories, Inc. at their Fairfield, New Jersey facility for further instructions and information regarding a potential refund or replacement.

For additional questions or to report a problem, contact the FDA at 1-888-463-6332 or visit www.fda.gov/medical-devices/medical-device-recalls.